Tim Harper

Back by popular demand is our Trashcompactor section. Something about this caught the imagination of a number of our readers,

Our apologies (and a slap on the wrist for one of our hacks) for not listing Eric Drexler as one

Despite the inherent weirdness of one Blog site referring to another, we felt compelled to go ahead with this one

After some years of relative silence, IBM’s Millipede project is back in the news. While analysts are questioning the real

The oft-quoted saying “Success has many fathers, but failure is an orphan” is certainly true when applied to nanotechnology. The

A rather garbled message comes across from the Swiss Re study we mentioned last week, or at least that’s how

We’re puzzled. Very puzzled in fact by the reaction to our item criticizing CiRN for advocating the use of ‘Nanomedicine’

As if the good name of nanotechnology was not sufficiently besmirched by nanobots, we see the emergence in Denmark of

was how I was rather embarrassingly introduced at a recent conference at the Swiss Stock Exchange. Does that then make

Another report which will definitely cause ripples is to be issued by one of the worlds largest reinsurance companies within